I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment: a meta-analysis

被引：0
|
作者：
Zhong-Ke Chen
Jing Fan
Fen-Qiang Li
Shi-Yan Zhou
Yuan-Shun Xu
机构：
[1] Affiliated Hospital of Gansu Medical College,Department of Interventional Therapy
[2] Lanzhou University First Affiliated Hospital,Interventional Radiology Department
[3] Xuzhou Central Hospital,Radiology Department
来源：
Journal of Cardiothoracic Surgery | / 17卷
关键词：
I-125 seed; Non-small-cell lung cancer; Progressive; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: A meta-analysis
    Griesinger, Frank
    Korol, Ellen E.
    Kayaniyil, Sheena
    Varol, Nebibe
    Ebner, Timo
    Goring, Sarah M.
    LUNG CANCER, 2019, 135 : 196 - 204
  • [32] Systematic review and network meta-analysis of first-line therapy for advanced EGFR-positive non-small-cell lung cancer
    Franek, Jacob
    Cappelleri, Joseph C.
    Larkin-Kaiser, Kelly A.
    Wilner, Keith D.
    Sandin, Rickard
    FUTURE ONCOLOGY, 2019, 15 (24) : 2857 - 2871
  • [33] Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis
    Haeussler, Katrin
    Wang, Xuan
    Winfree, Katherine B.
    D'yachkova, Yulia
    Traore, Sory
    Puri, Tarun
    Thom, Howard
    Papagiannopoulos, Christos
    Nassim, Maria
    Taipale, Kaisa
    FUTURE ONCOLOGY, 2022, 18 (16) : 2007 - 2028
  • [34] Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials
    Ku, Geoffrey Y.
    Haaland, Benjamin A.
    Lopes, Gilberto de Lima, Jr.
    LUNG CANCER, 2011, 74 (03) : 469 - 473
  • [35] Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer
    Reck, Martin
    IMMUNOTHERAPY, 2018, 10 (02) : 93 - 105
  • [36] Doublet Versus Single Cytotoxic Agent as First-Line Treatment for Elderly Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Wei-Xiang Qi
    Li-na Tang
    Ai-na He
    Zan Shen
    Feng Lin
    Yang Yao
    Lung, 2012, 190 : 477 - 485
  • [37] Doublet Versus Single Cytotoxic Agent as First-Line Treatment for Elderly Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Qi, Wei-Xiang
    Tang, Li-na
    He, Ai-na
    Shen, Zan
    Lin, Feng
    Yao, Yang
    LUNG, 2012, 190 (05) : 477 - 485
  • [38] PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysis
    Rossi, Antonio
    Di Noia, Vincenzo
    Gkountakos, Anastasios
    D'Argento, Ettore
    Sartori, Giulia
    Vita, Emanuele
    Monteverdi, Sara
    Lombardo, Fiorella
    Iacovelli, Roberto
    Carbognin, Luisa
    Sperduti, Isabella
    Milella, Michele
    Tortora, Giampaolo
    Bria, Emilio
    Pilotto, Sara
    IMMUNOTHERAPY, 2019, 11 (10) : 921 - 930
  • [39] Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
    Liang, Yi-Hsin
    Shao, Yu-Yun
    Liao, Bin-Chi
    Lee, Ho-Sheng
    Yang, James Chih-Hsin
    Chen, Ho-Min
    Chiang, Chun-Ju
    Cheng, Ann-Lii
    Lai, Mei-Shu
    JOURNAL OF CANCER, 2016, 7 (11): : 1515 - 1523
  • [40] Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials
    Bria, Emilio
    Cuppone, Federica
    Ciccarese, Mariangela
    Nistio, Cecilia
    Facciolo, Francesco
    Milella, Michele
    Izzo, Fiorentino
    Terzoli, Edmondo
    Cognetti, Francesco
    Giannarelli, Diana
    CANCER TREATMENT REVIEWS, 2006, 32 (08) : 583 - 587
12345